India shapes new production-linked incentives scheme for critical APIs to ensure self-reliance and cut massive dependence on imports from China, but much will depend on actual implementation, including timely clearances. Pharma will also need to 'walk the talk' alongside.
India has now outlined the details of a large-scale incentive scheme for manufacturers of certain critical active pharmaceutical ingredients (APIs) and drug intermediates in the country as it seeks to galvanize the domestic industry and shrink dependence on China.
The ministry of chemicals and fertilizers has provided the specifics of a production-linked incentive scheme to bolster domestic manufacturing of...
FDA regulation was painted as an obstacle to US dominance in the cell and gene therapy space even as panelists at an agency event praised the Office of Therapeutic Products' track record under Nicole Verdun.
As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.
Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.
